BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11996014)

  • 1. Update information on human P450s.
    Guengerich FP
    Drug Metab Rev; 2002; 34(1-2):7-15. PubMed ID: 11996014
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-drug interactions and the cytochrome P450 system: an update.
    Shannon M
    Pediatr Emerg Care; 1997 Oct; 13(5):350-3. PubMed ID: 9368253
    [No Abstract]   [Full Text] [Related]  

  • 3. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.
    Ingelman-Sundberg M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):89-104. PubMed ID: 14574440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytochrome P-450 (CYP) genes: a web page for the nomenclature of alleles.
    Ingelman-Sundberg M; Oscarson M; Daly AK; Garte S; Nebert DW
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1307-8. PubMed ID: 11751452
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytochrome p450 and chemical toxicology.
    Guengerich FP
    Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomenclature system for metabolic gene polymorphisms.
    Garte S; Crosti F
    IARC Sci Publ; 1999; (148):5-12. PubMed ID: 10493244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.
    Calinski DM; Zhang H; Ludeman S; Dolan ME; Hollenberg PF
    Drug Metab Dispos; 2015 Jul; 43(7):1084-90. PubMed ID: 25934575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of cytochrome p450s and personalized drug.
    Wang JF; Zhang CC; Chou KC; Wei DQ
    Curr Med Chem; 2009; 16(2):232-44. PubMed ID: 19149574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism of cytochrome P450s in beagles: possible influence of CYP1A2 deficiency on toxicological evaluations.
    Kamimura H
    Arch Toxicol; 2006 Nov; 80(11):732-8. PubMed ID: 16639591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug metabolism by the cytochrome p-450 enzyme. Variability of polymorphisms and exogenous carriers].
    Kreutzkamp B
    Med Monatsschr Pharm; 2006 Feb; 29(2):48-50. PubMed ID: 16506587
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of promutagens by human cDNA-expressed cytochrome P450s.
    Gonzalez FJ; Aoyama T; Gelboin HV
    Prog Clin Biol Res; 1990; 340B():77-86. PubMed ID: 2392453
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytochrome P-450 enzymes involved in genetic polymorphism of drug oxidation in humans.
    Guengerich FP; Beaune PH; Umbenhauer DR; Churchill PF; Bork RW; Dannan GA; Knodell RG; Lloyd RS; Martin MV
    Biochem Soc Trans; 1987 Aug; 15(4):576-8. PubMed ID: 3678578
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.
    Niwa T; Murayama N; Yamazaki H
    Curr Drug Metab; 2009 Sep; 10(7):700-12. PubMed ID: 19594405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytochrome p450 and their implication in chemotherapy].
    Delwaide PA
    Rev Med Liege; 1998 Nov; 53(11):700-10. PubMed ID: 9887664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualization of cancer therapy based on cytochrome P450 polymorphism: a pharmacogenetic approach.
    Vermes A; Guchelaar HJ; Koopmans RP
    Cancer Treat Rev; 1997; 23(5-6):321-39. PubMed ID: 9465883
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular and functional diversity of fungal cytochrome P450s.
    Ichinose H
    Biol Pharm Bull; 2012; 35(6):833-7. PubMed ID: 22687471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of rat P450 genetic polymorphism on diazepam metabolism.
    Sakai N; Ishizuka M
    Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1421-33. PubMed ID: 19689220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inhibitory monoclonal antibody to human cytochrome P450 that specifically binds and inhibits P4502C9II, an allelic variant of P4502C9 having a single amino acid change Arg144 Cys.
    Krausz KW; Goldfarb I; Yang TJ; Gonzalez FJ; Gelboin HV
    Xenobiotica; 2000 Jun; 30(6):619-25. PubMed ID: 10923863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function.
    Uno Y; Iwasaki K; Yamazaki H; Nelson DR
    Drug Metab Rev; 2011 Aug; 43(3):346-61. PubMed ID: 21303270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.